Skip to content
2000
Volume 8, Issue 1
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

The T cell factor 4 (Tcf-4) interacts with β-catenin in the Wnt signalling pathway and coactivates downstream target genes in diverse systems including the breast. This activity is important during normal development but its deregulation plays a pivotal role in cancer progression. In a rat model for breast cancer it has been shown that metastasis-inducing DNA (Met-DNA) sequesters the endogenous inhibitory Tcf-4 and thereby promotes transcription of the secreted extracellular matrix glycophosphoprotein, osteopontin, the direct effector of metastasis in this model system. Permanent transfection of the benign rat mammary cell line with a fragment from the Met-DNA containing the Tcf recognition sequence CAAAG induces the cells to metastasize in syngeneic rats in vivo. Tcf-4 expression in human breast carcinomas is inversely associated with osteopontin protein levels. High Tcf-4 expression impedes both OPN promoter activity and protein expression in rat mammary carcinoma cells. Understanding the role of Tcf-4 in cancer development and its transcription regulation should lay the foundation for novel therapeutic approaches in the future.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/156652408783565559
2008-02-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/156652408783565559
Loading

  • Article Type:
    Research Article
Keyword(s): cancer; metastasis; osteopontin; review; target genes; Tcf-4; Tcf/Lef; therapeutic targets; Wnt signalling
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test